SIBN Stock Cash Flow Statements

SI-BONE Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

SI-BONE Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31

cash flows from operating activities
net income	-6,152,000	-6,542,000	-4,495,000	-6,575,000	-8,939,000	-10,904,000	-10,983,000	-10,022,000	-11,206,000	-11,125,000	-11,175,000	-14,158,000	-18,513,000	-17,410,000	-14,477,000	-15,872,000	-13,981,000	-12,242,000	-8,979,000	-9,474,000	-12,472,000	-12,772,000	-9,098,000	-11,306,000	-8,654,000	-9,345,000	-5,313,000
adjustments to reconcile net income to net cash from operating activities:
stock-based compensation	6,658,000	6,663,000	6,135,000	6,306,000	6,398,000	7,030,000	5,937,000	5,928,000	5,998,000	6,194,000	5,881,000	5,922,000	5,751,000	5,507,000	4,338,000	4,241,000	4,257,000	4,030,000	3,170,000	3,180,000	2,955,000	2,622,000	1,868,000	1,911,000	1,814,000	1,871,000	1,231,000
depreciation and amortization	1,368,000	1,278,000	1,213,000	1,085,000	992,000	1,089,000	1,573,000	1,533,000	1,236,000	1,086,000	1,002,000	945,000	792,000	713,000	650,000	591,000	505,000	340,000	344,000	281,000	256,000	249,000	204,000	175,000	202,000	193,000	186,000
accounts receivable credit losses	384,000	91,000	142,000	88,000	158,000	82,000	409,000	249,000	53,000	50,000	100,000
amortization of discount and premium on marketable securities	-824,000	-916,000		-1,235,000	-1,458,000	-1,561,000
inventory reserve	841,000	394,000	682,000	252,000
amortization of debt issuance costs	30,000	29,000	26,000	42,000	43,000	42,000	43,000	42,000	42,000	81,000	46,000	51,000	50,000	51,000	54,000	59,000	87,000	88,000	88,000	104,000	35,000	65,000	65,000
loss on disposal of property and equipment	341,000	287,000	627,000	431,000	431,000	388,000	361,000	601,000	150,000	190,000
changes in operating assets and liabilities:
accounts receivable	2,046,000	552,000	-2,536,000	-282,000	-2,826,000	-196,000	-2,466,000	256,000	2,107,000	-2,019,000	-4,478,000	-1,281,000	-2,323,000	1,603,000	-1,629,000	-686,000	1,165,000	581,000	-2,249,000	-1,224,000	-920,000	2,207,000	-1,853,000	-467,000	-1,003,000	87,000	-1,380,000
inventory	-4,525,000	-3,767,000	-2,125,000	-2,608,000	-2,542,000	-772,000	320,000	-1,746,000	-2,757,000	-536,000	-531,000	-296,000	-1,704,000	-3,178,000	-1,239,000	-2,063,000	-757,000	-1,725,000	-611,000	-163,000	756,000	-256,000	-530,000	-483,000	-927,000	-165,000	-301,000
prepaid expenses and other assets	-587,000	494,000	-720,000	319,000	-125,000	524,000	-1,222,000	198,000	-49,000	311,000	-591,000	550,000	839,000	12,000	-1,204,000	453,000	137,000	20,000	-1,625,000	614,000	294,000	581,000	-909,000	292,000	269,000	-167,000	-1,247,000
accounts payable	-369,000	952,000	104,000	-71,000	-543,000	2,371,000	-242,000	-869,000	738,000	-745,000	1,053,000	540,000	-1,150,000	2,086,000	-957,000	-129,000	-505,000	1,059,000	419,000	706,000	-366,000	76,000	-143,000	188,000	-113,000	451,000	1,135,000
accrued liabilities and other	962,000	-4,426,000	3,311,000	2,550,000	1,711,000	-5,664,000	3,856,000	2,925,000	732,000	-3,625,000	2,294,000	1,012,000	1,072,000	-3,171,000	1,403,000	1,735,000	530,000	-1,945,000	1,306,000	217,000	5,000	-2,294,000	1,469,000	2,800,000	411,000	314,000	-584,000
net cash from operating activities	173,000	-4,911,000	1,178,000	302,000	-6,334,000	-7,571,000	-2,297,000	-2,073,000	-3,590,000	-10,753,000	-6,775,000	-6,527,000	-14,841,000	-13,512,000	-12,714,000	-9,309,000	-8,151,000	-9,359,000	-7,882,000	-5,552,000	-7,873,000	-9,355,000	-9,033,000	-7,120,000	-8,396,000	-7,078,000	-6,317,000
capex	-1,897,000	-1,257,000	-3,123,000	-2,884,000	-3,048,000	-854,000	-712,000	-1,803,000	-3,091,000	-1,692,000	-1,138,000	-4,572,000	-649,000	-2,033,000	-1,740,000	-55,000	-3,304,000	-781,000	-1,047,000	-369,000	-380,000	-832,000	-462,000	-772,000	-564,000	-272,000	-165,000
free cash flows	-1,724,000	-6,168,000	-1,945,000	-2,582,000	-9,382,000	-8,425,000	-3,009,000	-3,876,000	-6,681,000	-12,445,000	-7,913,000	-11,099,000	-15,490,000	-15,545,000	-14,454,000	-9,364,000	-11,455,000	-10,140,000	-8,929,000	-5,921,000	-8,253,000	-10,187,000	-9,495,000	-7,892,000	-8,960,000	-7,350,000	-6,482,000
cash flows from investing activities
maturities of marketable securities	44,100,000	60,000,000	42,000,000	67,500,000	52,000,000	67,000,000	44,000,000	24,500,000	39,000,000	30,000,000	36,000,000	42,200,000	23,000,000	25,000,000	52,496,000	50,517,000	23,777,000	33,200,000	41,516,000	29,700,000	12,500,000	21,000,000	42,700,000	33,500,000
purchases of marketable securities	-51,472,000	-47,298,000	-35,397,000	-60,695,000	-50,717,000	-58,571,000	-61,819,000	-77,957,000	-34,005,000	-15,718,000	-34,251,000	-29,901,000	-10,022,000	-45,334,000	-35,343,000	-23,341,000	-4,991,000	-38,346,000	-110,021,000	-34,377,000	-17,991,000	-16,777,000	-36,319,000	-25,029,000
purchases of property and equipment	-2,099,000	-2,072,000	-2,266,000	-3,036,000	-3,113,000	-2,082,000	-1,093,000	-1,413,000	-2,714,000	-2,579,000	-1,660,000	-3,572,000	-2,001,000	-2,274,000	-1,775,000	-423,000	-2,215,000	-1,976,000	-817,000	-480,000	-380,000	-884,000	-806,000	-746,000	-481,000	-412,000
net cash from investing activities	-9,471,000	10,630,000	4,337,000	3,769,000	-1,830,000	6,347,000	-18,912,000	-54,870,000	2,281,000	11,703,000	89,000	8,727,000	10,977,000	-22,608,000	15,378,000	26,753,000	16,571,000	-7,122,000	-67,819,000	-5,157,000	6,721,000	3,339,000	5,575,000	7,725,000	5,744,000	-5,553,000	-97,048,000
cash flows from financing activities
proceeds from issuance of common stock under employee stock purchase plan			682,000	0			720,000	0			619,000	0			777,000	0			924,000	0			940,000	0
proceeds from the exercise of stock options	665,000	103,000		155,000	304,000	105,000		229,000	3,515,000	520,000		106,000	30,000	169,000		1,076,000	650,000	601,000		628,000	185,000	174,000		611,000	442,000	125,000
net cash from financing activities	2,233,000	103,000	-78,000	155,000	1,776,000	105,000	842,000	-237,000	89,123,000	1,205,000	693,000	106,000	1,229,000	169,000	1,015,000	-5,543,000	2,216,000	601,000	73,038,000	467,000	-256,000	63,152,000	1,252,000	573,000	1,538,000	125,000	114,523,000
effect of exchange rate changes on cash and cash equivalents	28,000	417,000	-714,000	422,000	-75,000	-112,000	146,000	-143,000	32,000	97,000	411,000	-326,000	-375,000	-139,000	-123,000	-163,000	125,000	-337,000	248,000	69,000	9,000	-3,000	27,000	-60,000	49,000	-53,000	-42,000
net decrease in cash and cash equivalents													-3,010,000	-36,090,000								57,133,000		1,118,000	-1,065,000	-12,559,000	11,116,000
cash and cash equivalents at
beginning of period	0	34,948,000		0	0	33,271,000		0	0	20,717,000		0	0	63,419,000		0	0	53,581,000		0	0	10,435,000		0	0	25,120,000	0
end of period	-7,037,000	41,187,000		4,648,000	-6,463,000	32,040,000		-57,323,000	87,846,000	22,969,000		1,980,000	-3,010,000	27,329,000		11,738,000	10,761,000	37,364,000		-10,173,000	-1,399,000	67,568,000		1,118,000	-1,065,000	12,561,000	11,116,000
supplemental disclosure of non-cash information
unpaid purchases of property and equipment	202,000	815,000	-857,000	152,000	65,000	1,228,000	381,000	-390,000	-377,000	887,000	522,000	-1,000,000	1,352,000	241,000	35,000	368,000	-1,089,000	1,195,000	-230,000	111,000
net increase in cash and cash equivalents		6,239,000	4,723,000	4,648,000	-6,463,000	-1,231,000	-20,221,000	-57,323,000	87,846,000	2,252,000	-5,582,000				3,556,000	11,738,000	10,761,000	-16,217,000	-2,415,000	-10,173,000
adjustments to reconcile net income to net cash from operating activities
accretion (amortization) of discount and premium on marketable securities							-1,592,000	-1,168,000
changes in operating assets and liabilities
proceeds from follow-on public offering, net of underwriting discounts, commissions and offering costs																			71,638,000	0	0	62,978,000
proceeds from debt financing							0	0	0	36,000,000					0				0	0
repayments of debt financing							0	0	0	-35,275,000					0
payments of debt issuance costs							0	0	0	-40,000					0				0	-161,000
final payment fee related to debt
proceeds from the exercise of common stock options																											699,000
beginning of year
end of year
supplemental disclosure of cash flow information
cash paid for interest																											2,353,000
noncash investing and financing activities
operating lease right-of-use assets obtained in exchange for operating lease liabilities
proceeds from public offering, net of discounts, commissions and offering costs
public offering costs included in accounts payable																										167,000
proceeds from public offering, net of discounts and commissions
unpaid public offering costs
accretion (amortization) of discount on marketable securities										-615,000						335,000
accretion of discount on marketable securities											-396,000	110,000	271,000	244,000
loss on extinguishment of debt															0				0	0
loss on sale and disposal of property and equipment											20,000	28,000	74,000	31,000	95,000	179,000	21,000	104,000	128,000	168,000			19,000	54,000	1,000	97,000
payments of prepayment penalty and lender fees															0				0	0
vesting of early exercised stock options															0	9,000	9,000	9,000	9,000	9,000	26,000	27,000	36,000	39,000	56,000	66,000
bad debt expense																			-1,000	35,000
realized gain on marketable securities																			-3,000	0
sales of marketable securities																			1,503,000	0
principal repayments of debt financing																			0	0
unpaid debt issuance costs
accretion on marketable securities																		331,000		4,000	5,000	-25,000	-125,000	-348,000
repurchase of unvested early exercised stock options																							0
payments of initial public offering costs
payments of additional initial public offering related costs
bad debts expense																						192,000
purchases of property and equipment included in accounts payable and accrued liabilities																						52,000	344,000	-26,000	-83,000	140,000
change in fair value of redeemable convertible preferred stock warrants																											145,000
proceeds from initial public offering, net of underwriting discounts and commissions
payments of public offering costs																							0	0			-1,609,000
conversion of redeemable convertible preferred stock to common stock
conversion of preferred stock warrants to common stock warrants
amortization of debt discount																									65,000	65,000	65,000
short-term investment accretion																										-479,000
purchases of short-term investments																										-22,741,000
maturities of short-term investments																										17,600,000
change in allowance for doubtful accounts																											-2,000
loss on write-off of property and equipment																											-43,000
write-off of debt discount
write-off of public offering costs
forgiveness of notes receivable
short-term investments accretion
purchase of property and equipment																											-165,000
purchase of short-term investments
repurchase of common stock
repayment of stockholders’ notes receivable
repayment of debt financing
extinguishment of debt financing
payment of debt issuance costs
proceeds from the issuance of redeemable convertible preferred stock
supplemental disclosure of noncash information
public offering costs included in accounts payable and accrued liabilities

We provide you with 20 years of cash flow statements for SI-BONE stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SI-BONE stock. Explore the full financial landscape of SI-BONE stock with our expertly curated income statements.

The information provided in this report about SI-BONE stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.